Finance

Beta
Ask
Lists
EVH:NYSE
Evolent Health Inc
$4.67
-0.64%
(-0.030) 1D
$4.67
0.00% (0.00)
After hours
Closed: Jun 17, 4:00:03 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EVH...
Open
$4.67
High
$4.86
Low
$4.57
Mkt. cap
525.29M
Avg. vol.
2.71M
Volume
0.00
52-wk high
$12.06
52-wk low
$2.10
EPS
-$4.76
Beta
0.84
Shares outstanding
112.48M
No. of employees
4K
Open
$4.67
High
$4.86
Low
$4.57
Mkt. cap
525.29M
Avg. vol.
2.71M
Volume
0.00
52-wk high
$12.06
52-wk low
$2.10
EPS
-$4.76
Beta
0.84
Shares outstanding
112.48M
No. of employees
4K
Analyst outlook
Analyst Ratings
Based on 11 analysts giving stock ratings to EVH in the past 3 months
Strong Buy
Buy
9
Hold
2
Sell
0
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for EVH in the last 3 months.
Highest
Current $4.67
$8.00 (+71.31%)
Average
$5.69 (+21.84%)
Lowest
$3.00 (-35.76%)
News stories
From sources across the web
About Evolent Health Inc
CEO-
Employees4.2K
Founded2011
Headquarters-
SectorHealth care
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.02 / -$0.05
+57.17%beat
Revenue / Est. (USD)
496.25M / 534.04M
-7.08%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
444.33M
479.53M
468.72M
496.25M
Cost of goods sold
343.94M
379.76M
371.47M
412.47M
Cost of revenue
343.94M
379.76M
371.47M
412.47M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
74.42M
75.50M
61.86M
72.36M
Operating expense
97.56M
99.12M
106.89M
93.91M
Total operating expenses
441.50M
478.88M
478.36M
506.38M
Operating income
2.83M
658.00K
-9.64M
-10.14M
Other non operating income
-231.00K
80.00K
-552.00K
742.00K
EBT including unusual items
-20.72M
-19.96M
-430.81M
-25.72M
EBT excluding unusual items
-7.72M
-14.62M
-28.30M
-25.26M
Income tax expense
-825.00K
906.00K
-1.68M
910.00K
Effective tax rate
3.98%
-4.54%
0.39%
-3.54%
Other operating expenses
-
-
-
-
Net income
-19.90M
-20.86M
-429.13M
-26.63M
Net profit margin
-4.48%
-4.35%
-91.55%
-5.37%
Earnings per share
-0.10
0.05
-
-0.02
Interest and investment income
1.08M
964.00K
868.00K
1.01M
Interest expense
-11.60M
-16.48M
-19.01M
-16.87M
Net interest expenses
-10.52M
-15.51M
-18.14M
-15.85M
Depreciation and amortization charges
23.14M
23.62M
45.04M
21.56M
EBITDA
20.37M
18.67M
29.70M
5.62M
Gain or loss from assets sale
-
-
-14.87M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more